Orbia Advance Corporation S.A.B. de C.V.

What it is

Orbia makes the unglamorous things modern life runs on: plastic pipes, irrigation kit, telecom ducts and specialty chemicals. It sells through five business arms, each with its own brand.

These include Netafim for farm irrigation, Wavin for building pipes, Koura for fluorine-based materials used in healthcare and construction, and Dura-Line for communication and power cables. The group was once a Mexican commodity-chemicals firm called Mexichem.

Who owns it

One family controls Orbia: the del Valle family, through their holding company Grupo Empresarial Kaluz. The del Valle family, through Kaluz, holds about 45.8% of Orbia’s shares, with four family members serving as directors.

A controlling group and related investors together own around 55.5%. That matches the structured data, which shows insiders holding 55.54% — meaning roughly 44% trades freely (the free float), with funds owning about 21%.

Who runs it

The chief executive is Sameer Bharadwaj. He has led the company since 2021, after serving as President of its Fluor and Polymer Solutions businesses, having joined in 2016.

The board chairman is Juan Pablo del Valle Perochena, the controlling family’s representative. He has been chairman since 2011, overseeing the company’s evolution into a global materials group.

A new finance chief has just arrived. After a succession process, the board appointed Cristian “Cape” Capellino as Chief Financial Officer effective March 15, 2026; he joined Orbia in 2020 and previously led roles across controllership, tax and finance transformation.

The money, in plain words

Orbia is shrinking, not growing. In 2024 it reported a net profit of US$145 million.

In 2025 that flipped to a loss of US$457 million — the business spent more than it earned.

Sales slipped too: revenue fell from US$8.20bn in 2023 to US$7.62bn in 2025, a drop of about 7% (our calculation). For every dollar of sales last year it lost about 6 cents — a net margin of –6.0% (our calculation).

The owners are also going backwards. The company turned a loss equal to about 12 cents on each dollar of their money — a return on equity of –12.0%, the structured data shows.

One bright spot: it holds US$1.04bn in cash against US$8.43bn of total debts and obligations. The balance sheet is strained, but the cash buffer is real.

What it is doing now

Management’s whole story right now is discipline, not expansion. The CEO says the company remains “relentlessly focused” on financial discipline, calling 2025’s markets challenging, especially in construction, infrastructure, Europe and Mexico.

Early 2026 trading was steady rather than spectacular. In the first quarter of 2026 Orbia reported revenues of US$1.96 billion and earnings before interest, tax and one-off items of US$259 million.

It is also betting on healthcare chemistry. In February 2026 it announced the CFO change; separately it is scaling up Zephex 152a, a cleaner propellant for asthma inhalers, after a U.S. regulatory approval and a new U.K.

plant.

What to watch

The key question is whether Orbia can turn its loss back into profit. Watch for a return to positive net income and a recovery in construction demand, its biggest swing factor.

Also watch the debt. With heavy borrowings against a modest cash pile, every quarter of weak cash generation tightens the squeeze on a family-controlled group with little room for error.

This is news, not investment advice.